FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Míriam Molina-Arcas

Research Profile

Chemicals & Drugs

Physiology

Anatomy

Disorders

B-Cell Chronic Lymphocytic Leukemia

Procedures

Reverse Transcriptase Polymerase Chain Reaction

Co-author Network

Publications

TOP 3
Laia Trigueros-Motos; Sandra Pérez-Torras; F Javier Casado; Míriam Molina-Arcas; Marçal Pastor-Anglada
Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs.
Ekaitz Errasti-Murugarren; Míriam Molina-Arcas; F Javier Casado; Marçal Pastor-Anglada
The human concentrative nucleoside transporter-3 C602R variant shows impaired sorting to lipid rafts and altered specificity for nucleoside-derived drugs.
Míriam Molina-Arcas; Marçal Pastor-Anglada
Role of nucleoside transporters in nucleoside-derived drug sensitivity.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Míriam Molina-Arcas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Laia Trigueros-Motos; Sandra Pérez-Torras; F Javier Casado; Míriam Molina-Arcas; Marçal Pastor-Anglada
Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs.
BMC cancer 2012;12():434.
2010: Ekaitz Errasti-Murugarren; Míriam Molina-Arcas; F Javier Casado; Marçal Pastor-Anglada
The human concentrative nucleoside transporter-3 C602R variant shows impaired sorting to lipid rafts and altered specificity for nucleoside-derived drugs.
Molecular pharmacology 2010;78(2):157-65.
2010: Míriam Molina-Arcas; Marçal Pastor-Anglada
Role of nucleoside transporters in nucleoside-derived drug sensitivity.
Nucleosides, nucleotides & nucleic acids 2010;29(4-6):335-46.
2009: Míriam Molina-Arcas; F Javier Casado; Marçal Pastor-Anglada
Nucleoside transporter proteins.
Current vascular pharmacology 2009;7(4):426-34.
2009: Gerard Minuesa; Christopher Volk; Míriam Molina-Arcas; Valentin Gorboulev; Itziar Erkizia; Petra Arndt; Bonaventura Clotet; Marçal Pastor-Anglada; Hermann Koepsell; Javier Martinez-Picado
Transport of lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3.
The Journal of pharmacology and experimental therapeutics 2009;329(1):252-61.
2009: Ekaitz Errasti-Murugarren; Míriam Molina-Arcas; F Javier Casado; Marçal Pastor-Anglada
A splice variant of the SLC28A3 gene encodes a novel human concentrative nucleoside transporter-3 (hCNT3) protein localized in the endoplasmic reticulum.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2009;23(1):172-82.
2008: Mónica López-Guerra; Laia Trigueros-Motos; Míriam Molina-Arcas; Neus Villamor; F Javier Casado; Emili Montserrat; Elias Campo; Dolors Colomer; Marçal Pastor-Anglada
Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells.
Haematologica 2008;93(12):1843-51.
2008: Míriam Molina-Arcas; Laia Trigueros-Motos; F Javier Casado; Marçal Pastor-Anglada
Physiological and pharmacological roles of nucleoside transporter proteins.
Nucleosides, nucleotides & nucleic acids 2008;27(6):769-78.
2008: Pedro Cano-Soldado; Míriam Molina-Arcas; Berta Algueró; Ignacio Larráyoz; M Pilar Lostao; Anna Grandas; F Javier Casado; Marçal Pastor-Anglada
Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells.
Biochemical pharmacology 2008;75(3):639-48.
2008: Gerard Minuesa; Sergi Purcet; Itziar Erkizia; Míriam Molina-Arcas; Margarita Bofill; Nuria Izquierdo-Useros; F Javier Casado; Bonaventura Clotet; Marçal Pastor-Anglada; Javier Martinez-Picado
Expression and functionality of anti-human immunodeficiency virus and anticancer drug uptake transporters in immune cells.
The Journal of pharmacology and experimental therapeutics 2008;324(2):558-67.
2006: Míriam Molina-Arcas; Gema Moreno-Bueno; Pedro Cano-Soldado; Héctor Hernández-Vargas; F Javier Casado; José Palacios; Marçal Pastor-Anglada
Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5'-DFUR in breast cancer MCF7 cells.
Biochemical pharmacology 2006;72(12):1646-56.
2006: Silvia Marcé; Míriam Molina-Arcas; Neus Villamor; F Javier Casado; Elias Campo; Marçal Pastor-Anglada; Dolors Colomer
Expression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphoma.
Haematologica 2006;91(7):895-902.
2006: Sergi Purcet; Gerard Minuesa; Míriam Molina-Arcas; Itziar Erkizia; F Javier Casado; Bonaventura Clotet; Javier Martinez-Picado; Marçal Pastor-Anglada
3'-Azido-2',3'-dideoxythymidine (zidovudine) uptake mechanisms in T lymphocytes.
Antiviral therapy 2006;11(6):803-11.
2005: Marçal Pastor-Anglada; Pedro Cano-Soldado; Míriam Molina-Arcas; M Pilar Lostao; Ignacio M Larráyoz; Javier Martínez-Picado; F Javier Casado
Cell entry and export of nucleoside analogues.
Virus research 2005;107(2):151-64.
2005: Míriam Molina-Arcas; Silvia Marcé; Neus Villamor; Isabel Huber-Ruano; F Javier Casado; Beatriz Bellosillo; Emili Montserrat; Joan Gil; Dolors Colomer; Marçal Pastor-Anglada
Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells.
Leukemia 2005;19(1):64-8.
2004: Pedro Cano-Soldado; Ignacio M Lorráyoz; Míriam Molina-Arcas; F Javier Casado; Javier Martinez-Picado; M Pilar Lostao; Marçal Pastor-Anglada
Interaction of nucleoside inhibitors of HIV-1 reverse transcriptase with the concentrative nucleoside transporter-1 (SLC28A1).
Antiviral therapy 2004;9(6):993-1002.
2004: Marçal Pastor-Anglada; Míriam Molina-Arcas; F Javier Casado; Beatriz Bellosillo; Dolors Colomer; Joan Gil
Nucleoside transporters in chronic lymphocytic leukaemia.
Leukemia 2004;18(3):385-93.
2003: José García-Manteiga; Míriam Molina-Arcas; F Javier Casado; Adela Mazo; Marçal Pastor-Anglada
Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(13):5000-8.
2003: Míriam Molina-Arcas; Beatriz Bellosillo; F Javier Casado; Emili Montserrat; Joan Gil; Dolors Colomer; Marçal Pastor-Anglada
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia.
Blood 2003;101(6):2328-34.